How To Use Atrial fibrillation In A Sentence
-
Additionally, FDA officials decided the drug must carry a warning on its label stating, "An increased rate of stroke was observed following Xarelto discontinuation in clinical trials" in patients with the faulty heartbeat known as atrial fibrillation.
FDA Approves Anticlotting Drug
-
SANJAY GUPTA, CNN CHIEF MEDICAL CORRESPONDENT: The heart condition we're talking about is atrial fibrillation, which is a relatively common problem.
CNN Transcript Apr 29, 2008
-
An increase of vagal tone after exercise occasionally can lead to episodes of atrial fibrillation.
-
Guidelines for anticoagulation in atrial fibrillation based on absolute risk or clinical criteria have been widely promulgated.
-
A fluttery heartbeat can also be a sign of a common condition called atrial fibrillation.
-
Adult patients more than 18 years of age were eligible if they had acute ischemic stroke and atrial fibrillation.
-
After discharge, patients recorded and transmitted their rhythm by telephone daily and whenever they had symptoms suggestive of atrial fibrillation.
-
Atrial fibrillation is less common among hypertensive patients taking long-term monotherapy with ACE inhibitors, angiotensin II-receptor blockers (ARBs), or beta-blockers than among those on calcium channel blockers, the
Medlogs - Recent stories
-
If and when the clinical trials comparying "riva" with warfarin in chronic atrial fibrillation demonstrates similar good results we may finally have a new oral anticoagulant than does not require frequent blood test monitoring and may be free of much of the vexing vagaries of trying to get the dose of warfarin right and keeping it there. posted by james gaulte @ 4:05 AM
This time,new oral anticoagulants may well make it to the market
-
A common treatment for atrial fibrillation includes an older, generic drug called amiodarone, but it is associated with side effects such as damage to the lung and liver, and muscle weakness.
Sanofi to Resubmit Heart Drug
-
Atrial fibrillation occurs when the heart's upper chambers (called atria) quiver, instead of beating properly, and this disruption may allow blood to pool or clot, raising the risk of stroke.
EurekAlert! - Breaking News
-
To cope with this risk, most patients with atrial fibrillation need to take an anticoagulant such as coumadin their entire lives.
Medgadget
-
ObjectiveTo compare the efficacy and safety of intravenous amiodarone versus propafenone for immediate cardioversion of re cent-onset atrial fibrillation.
-
Underlying causes of atrial fibrillation should be treated, including infection, congestive heart failure, hypoxia, hypokalemia and pneumonia.
-
Its role in the management of atrial fibrillation has definitely diminished as other, more effective agents are commonly used in the treatment of this dysrhythmia.
-
In the absence of atrial fibrillation the use of digoxin and digitoxin has been more controversial and until recently it was evaluated in randomised controlled trials with major methodological flaws.
-
The study showed that men who express their anger have a 10 percent greater risk than non-hostile men of developing an atrial fibrillation, a heart flutter.
-
An increase of vagal tone after exercise occasionally can lead to episodes of atrial fibrillation.
-
Digoxin is incapable of converting atrial fibrillation or atrial flutter to a normal sinus rhythm.
-
WASHINGTON—Food and Drug Administration staff recommended against an immediate approval for Johnson & Johnson and Bayer AG's anticlotting drug Xarelto as a treatment to prevent strokes in patients with atrial fibrillation.
Bayer, J&J Suffer FDA Setback
-
OSA was associated with greater body mass index, whereas CSA was associated with atrial fibrillation, hypocapnia, and diuretic use.
Health News from Medical News Today
-
Atrial fibrillation is the most common chronic arrhythmia and is a major risk factor for stroke.
-
Trials are in progress to evaluate pacemakers that detect trends in heart rate and ectopy known to be associated with paroxysms of atrial fibrillation and that initiate single site or multisite pacing in response to these changes.
-
A series of unsuccessful attempts at scheduling surgery for her sigmoid colectomy followed because of complications with her neutrophil count and hospitalization for new onset atrial fibrillation.
-
Wide concern has been expressed that when such criteria are used, atrial fibrillation is being undertreated in elderly people.
-
Chronic atrial fibrillation is associated with an increased risk of death.
-
Despite a long history of use in the treatment of paroxysmal atrial fibrillation, the efficacy of cardiac glycosides has not been established.
-
The system could be used to detect the activation path of atrial fibrillation and ventricular fibrillation.
-
Abnormal findings on examination included decreased breath sounds, tachypnea, rapid atrial fibrillation with a ventricular rate as high as 170, splenomegaly, and a right-sided abdominal mass.
-
Symptoms of atrial fibrillation are generally due to hemodynamic derangements that are the result of loss of atrial contraction and increased ventricular response.
-
Sanofi developed Multaq as a so-called antiarrhythmic drug to treat atrial fibrillation, which affects about 2.2 million Americans and 4.5 million people in the European Union, according to figures from the American Heart Association and Sanofi.
Sanofi to Resubmit Heart Drug
-
One doctor reaches for a ‘decent dose of warfarin and digoxin no hesitation at all’ to treat patients with atrial fibrillation because of the death of a grandfather.
-
Seven months after the lung tumor was resected, the patient developed a left temporoparietal infarction that resulted from embolic occlusion of the left middle cerebral artery secondary to atrial fibrillation.
-
Digoxin has an important role in the symptomatic treatment of patients with heart failure and atrial fibrillation.
-
Patients with atrial fibrillation also had more drug days for diuretics and for electrolytes.
-
The atrial fibrillation group also had more hematologic tests done, including more prothrombin and partial thromboplastin times.
-
2002, Medicare approved coverage for home testing for patients on anticoagulation therapy with prosthetic heart valves, and in 2008, it expanded the availability of home testing to those who need long-term anticoagulation therapy, such as people with the heart condition atrial fibrillation.
Yahoo! News: Business - Opinion
-
Patients with atrial fibrillation (irregular beating of the heart) may be prescribed anticoagulants.
-
The resultant irregular rhythm may be difficult to differentiate from atrial fibrillation.
-
Nonvalvular atrial fibrillation is well known as an independent risk factor for stroke, and millions of patients with this cardiac dysrhythmia are also at risk for cardiogenic embolism.
-
Digoxin is incapable of converting atrial fibrillation or atrial flutter to a normal sinus rhythm.
-
To correct your condition, doctors may be able to reset your heart to its regular rhythm (sinus rhythm) using a procedure called cardioversion, depending on the underlying cause of atrial fibrillation and how long you've had it.
Find Me A Cure
-
Around half of the study patients had atrial fibrillation as their primary indication for warfarin.
-
This guideline provides an outline for the care of the majority of patients with atrial fibrillation.
-
Xarelto, which Bayer developed with Johnson & Johnson , is set to be used as an antiblood clotter in patients with atrial fibrillation, a heart rhythm disorder that puts people at risk of stroke.
EU Backs Bayer's Blood Thinner
-
A big chunk of those sales projections, however, is premised on the drug also receiving approval in the U.S. and Europe for the prevention of stroke in people with a heart-rhythm disorder known as atrial fibrillation.
E.U. Approves Blood Thinner From Bristol-Myers, Pfizer
-
ObjectiveTo compare the efficacy and safety of intravenous amiodarone versus propafenone for immediate cardioversion of re cent-onset atrial fibrillation.
-
Of more interest is a sub-group of patients with runs of atrial ectopy, which degenerate to paroxysms of atrial fibrillation.
-
Weakness and atrial fibrillation ( AF ) were observed more frequently in single TIA than in multiple TIA ( P ＜0,05 ).
-
It is not uncommon for this rhythm to progress into atrial flutter or atrial fibrillation.
-
Patients should be monitored for an exacerbation of atrial fibrillation or flutter, and for increasing ventricular rates.
-
Atrial fibrillation was less common if patients were on long-term monotherapy with ACE inhibitors (odds ratio, 0.77), ARBs (0.75), or beta-blockers (0.80), than if they were on calcium channel blockers.
Medlogs - Recent stories
